Type III secretion systems (T3SSs) are multiprotein molecular devices used by many Gram-negative bacterial pathogens to translocate effector proteins into eukaryotic cells. A T3SS is also used for protein export in flagellar assembly, which promotes bacterial motility. The two systems are evolutionarily related, possessing highly conserved components in their export apparatuses. Enteropathogenic Escherichia coli (EPEC) employs a T3SS, encoded by genes in the locus of enterocyte effacement (LEE) pathogenicity island, to colonize the human intestine and cause diarrheal disease. In the present work, we investigated the role of the LEE-encoded EscO protein (previously Orf15 or EscA) in T3SS biogenesis. We show that EscO shares similar properties with the flagellar FliJ and the Yersinia YscO protein families. Our findings demonstrate that EscO is essential for secretion of all categories of T3SS substrates. Consistent with its central role in protein secretion, it was found to interact with the ATPase EscN and its negative regulator, EscL, of the export apparatus. Moreover, we show that EscO stimulates EscN enzymatic activity; however, it is unable to upregulate ATP hydrolysis in the presence of EscL. Remarkably, EscO partially restored the swimming defect of a Salmonella flagellar fliJ mutant and was able to stimulate the ATPase activity of FliI. Overall, our data indicate that EscO is the virulence counterpart of the flagellar FliJ protein.
T he virulence of many plant and animal bacterial pathogens is mediated by type III secretion systems (T3SSs) (1, 2) . The pathogenic T3SS, called the "injectisome" or "needle complex," is a macromolecular structure that spans the inner and outer membranes of bacteria and the cytoplasmic membrane of host target cells to deliver effector proteins into the eukaryotic cytoplasm (3, 4) . An evolutionarily related nonpathogenic T3SS is used for flagellar assembly, and several proteins of the virulence and flagellar secretion machineries show extensive similarity (5, 6) . Recently, through phylogenomic and comparative analyses, it was proposed that the nonflagellar T3SS evolved by recruiting part of the bacterial flagellum structure and adapting a new protein secretion function (7) .
Enteropathogenic Escherichia coli (EPEC) encodes a T3SS within a chromosomal pathogenicity island named the locus of enterocyte effacement (LEE) (8, 9) . This secretion system mediates the translocation of multiple virulence effectors (encoded by genes in the LEE or elsewhere in the chromosome, with the latter referred to as Nle, for non-LEE encoded) into enterocyte cells, generating a characteristic intestinal histopathology termed an attaching and effacing (A/E) lesion and eventually causing diarrheal disease (10, 11) . EPEC is a leading agent of infantile diarrhea in developing countries (12) . Epidemiological studies in Mexico indicate that 17 to 19% of infant diarrhea is due to EPEC infection (13) . This pathotype belongs to a family of other LEE-containing pathogens producing the A/E phenotype, including enterohemorrhagic E. coli (EHEC) and the mouse pathogen Citrobacter rodentium (8, 14) .
More than 20 proteins participate in assembling the T3SS in EPEC. This molecular nanomachine consists of a membranespanning cylindrical basal body connected to an extracellular filamentous structure formed by the needle (EscF) and the filament (EspA) that serves as a conduit for effector transport (15) (16) (17) . EspA assists with the formation of a translocation pore (formed by EspB and EspD subunits) in the enterocyte cell membrane through which effectors are translocated (18) . EspA, EspB, and EspD form the translocon and are collectively known as translocators (19) .
The basal body is formed by a set of ring structures associated with the inner (EscJ, EscD) and outer (EscC) bacterial membranes and a periplasmic inner rod (EscI) (20) (21) (22) (23) . In addition, the basal structure houses the type III export apparatus, composed of five integral inner membrane proteins essential for protein secretion (EscR, EscS, EscT, EscU, and EscV) (3) . These components are extensively conserved among different virulence T3SSs and in the flagellar export apparatus: EscR in EPEC (FliP in the flagellar T3SS), EscS (FliQ), EscT (FliR), EscU (FlhB), and EscV (FlhA) (1, 5, 24) . Moreover, the flagellar export apparatus includes three soluble components (FliI, FliH, and FliJ) that form the ATPase complex and have been shown to be evolutionarily related to components of the V o V 1 and F o F 1 rotary ATPases (24) (25) (26) (27) (28) (29) . The ATPase complex is believed to participate in the initial sorting and entry of substrates into the export gate, while the translocation of substrates into the flagellar central channel is driven by the proton motive force (24, (30) (31) (32) .
In EPEC, EscN (the FliI homolog) is the T3SS ATPase that has been shown to be essential for functional T3 translocation. It shows sequence and structural similarity to the F 1 ATPase ␣ and ␤ subunits and is thought to oligomerize into a homohexameric ring structure that resembles the ␣ 3 ␤ 3 heterohexamer of the F 1 ATPase (33) (34) (35) . EscN forms a complex with EscL (FliH), a putative ATPase-negative regulator, and with EscQ (FliN), a predicted component of the cytoplasmic C ring (36) . EscL is thought to inhibit the ATPase activity, as has been reported for its counterparts YscL in Yersinia and the flagellar FliH protein (37, 38) . FliH has sequence similarity to the b and ␦ subunits of the F o F 1 ATPase, which form the peripheral stalk that is essential for connecting F 1 to the F o sector and that functions as a stator during rotational catalysis (26) . To date, no homolog of FliJ has been identified in the EPEC T3SS. However, due to a conserved gene order and similar protein properties, this flagellar protein has been related to the virulence counterparts YscO (Yersinia), InvI (Salmonella), Spa13 (Shigella), CT670 (renamed CdsO; Chlamydia), and HrpO (Pseudomonas) (39) (40) (41) (42) (43) (44) .
FliJ is a soluble component of the flagellar ATPase complex required for the export of structural subunits (45, 46) . It interacts with FliH, FliI, the cytoplasmic domains of the membrane export apparatus components FlhA and FlhB (FlhA C and FlhB C ) and the C-ring protein FliM (47) (48) (49) (50) . The crystal structure of FliJ shows structural similarity to the ␣-helical coiled-coil region of the F o F 1 ATPase ␥ subunit, and it was shown that FliJ promotes the formation of the FliI homohexamer by binding to the center of the ring in a manner similar to that in which the ␥ subunit penetrates into the central pore of the ␣ 3 ␤ 3 F 1 ATPase heterohexamer (28) . Furthermore, it has been shown that FliJ, together with FlhA, is involved in the energy-coupling mechanism of the proton motive force-driven export of flagellar substrates (30) . Recently, an export nonameric ring formed by subunits of the FlhA virulence counterpart MxiA (Shigella) was localized above the ATPase complex by electron cryotomography (51) , and this was also observed for InvA (Salmonella) and FlhA (flagellum) (6) .
An additional function of FliJ as an escort chaperone has been described in which it recruits unloaded chaperones and transfers them to the minor filament-class subunits to facilitate their export (40) . Moreover, it has been shown that the FliJ counterparts in the type III secretion (T3S) virulence system (InvI, YscO, and Spa13) also bind chaperones of the translocation pore components (43, 44) . Although important insights into the role of FliJ in the flagellar system have been obtained, the precise function of its counterparts in the pathogenic T3SSs remains unclear.
Orf15 is a small protein of 125 amino acids encoded by the fourth gene of the LEE3 operon which has been shown to be essential for protein secretion and virulence in C. rodentium (52) . A recent study in EPEC showed that this protein is required for translocator protein secretion, localizes to the periplasm, and interacts with the outer membrane secretin EscC, suggesting that it has a structural role within the T3SS (53) . Since no homologs of Orf15 have been found in non-A/E pathogens or in the flagellar T3SSs (53, 54) , the protein was named EscA (53) . In the present study, we provide evidence showing that Orf15 is a member of the Yersinia YscO and the flagellar FliJ family of proteins. Therefore, to avoid confusion in the literature and taking into consideration the fact that the protein nomenclature in EPEC is based on that of Yersinia spp. (55), we propose renaming it EscO. This nomenclature will be used here. In this work, we undertook the functional characterization of EscO. We demonstrate that EscO is a component of the export ATPase complex and that it participates in the regulation of ATPase hydrolytic activity. We also show that EscO is able to rescue the phenotype of a deletion mutant strain in its flagellar counterpart. Overall, our results suggest that EscO functions like FliJ, as an F 1 ␥-subunit-like component of the EPEC T3SS.
(This study was performed in partial fulfillment of the requirements for the Ph.D. degree in biomedical sciences of M.R.-C. at the Universidad Nacional Autónoma de México.)
MATERIALS AND METHODS
Bacterial strains and growth conditions. The bacterial strains used in this study are listed in Table 1 . Bacteria were grown either in Luria-Bertani (LB) broth (56) at 37°C with shaking or in preequilibrated Dulbecco's modified Eagle's medium (DMEM; Gibco) containing 1% LB broth under static conditions at 37°C in a 5% CO 2 atmosphere. Cultures were supplemented as required with ampicillin (100 g/ml), chloramphenicol (25 g/ml), kanamycin (50 g/ml), streptomycin (25 g/ml), or tetracycline (25 g/ml).
DNA manipulations. Routine DNA procedures were performed using standard molecular methods (56) . Restriction enzymes and T4 DNA ligase were obtained from New England BioLabs and used according to the manufacturer's instructions. PCRs were performed with Taq DNA polymerase (Qiagen) or PfuTurbo DNA polymerase (Stratagene) using synthetic primers from Sigma. The sequencing facility at the Instituto de Fisiología Celular, Universidad Nacional Autónoma de México (UNAM), performed DNA sequencing. The plasmids and primers used in this study are listed in Tables 1 and 2 , respectively.
Plasmid construction. The escO, escN, and escL genes were PCR amplified using chromosomal DNA from an EPEC wild-type (WT) strain as the template with the primer pairs escO_Fw/escO_Rv, escN_Fw/ escN_Rv, and escL_Fw/escL_Rv, respectively. The resulting escO PCR product was cloned into the pGEM-T Easy vector (Promega) to generate plasmid pMMescO and subsequently subcloned into the NdeI-BamHI sites of the pET19b, pTrc99AFF4, and pACTrc vectors, yielding plasmids pNEescO, pMTescO, and pMATescO, respectively. The pNEescO construct was used for gene subcloning into the NcoI-BamHI sites of pTrc99A to generate plasmid pMTHescO. The resulting escN PCR product was cloned into the NdeI-BamHI sites of the pUC18 vector to produce plasmid pAUescN. This plasmid was used for escN subcloning into the same restriction sites of the pET19b vector to generate plasmid pAEescN, which was used for gene subcloning into pTrc99AFF4 to generate plasmid pATescN. The escL PCR product was cloned into the PCR-Blunt II-TOPO vector to generate pARescLBS. This construct was used for gene subcloning into the BamHI-SalI sites of the pQE30 expression vector to generate the pAQescL plasmid. In addition, a truncated version of EscL lacking the first 89 residues was constructed. Chromosomal DNA was amplified using the primer pair escL89_Fw/escL_Rv. The resulting PCR product was cloned into the BamHI-SalI sites of the pQE30 vector to generate plasmid pAQescL ⌬89 . All constructs were verified by DNA sequencing.
Site-directed mutagenesis was accomplished following the protocol from the QuikChange kit (Stratagene). Plasmid pAEescN K183E was generated with the primer pair escN K183E_ Fw/escN K183E_ Rv using plasmid pAEescN as the template. Plasmid pAEescN K183E was used for gene subcloning into the NdeI-BamHI sites of the pTrc99AFF4 vector to generate plasmid pMTescN K183E . Introduction of the desired point mutation was confirmed by DNA sequencing.
Construction of escO-null mutant. The EPEC ⌬escO nonpolar mutant strain was generated using the bacteriophage Red recombinase system (57) . The escO gene was replaced with a kanamycin resistance marker. A PCR product containing the kanamycin resistance cassette was generated from the template plasmid pKD4 using the primer pair ⌬escO_Fw/⌬escO_Rv ( Table 2 ). The resulting PCR product was electroporated into the EPEC WT strain carrying the Red recombinase expression plasmid pKD46. Kanamycin-and streptomycin-resistant and ampicillin-sensitive recombinants were selected at 37°C on LB agar plates. escO gene disruption was confirmed by PCR using primers flanking the targeted region (escO_Fw and escO_Rv) as well as primers whose sequences were homologous to sequences in the antibiotic resistance gene (K1, K2, and KT) (57) . Type III protein secretion assay. EPEC protein secretion assays were performed in DMEM under static conditions. A total of 120 l of an overnight LB broth culture of the indicated EPEC strain was inoculated in 6 ml of DMEM, and growth was continued for 6 h. The culture supernatant was collected by centrifugation at 26,000 ϫ g for 5 min, and the resulting pellet was resuspended in Laemmli sample buffer and normalized to the optical density at 600 nm (OD 600 ). Proteins in the supernatant were precipitated by the addition of 10% ice-cold trichloroacetic acid, incubated at 4°C overnight, and centrifuged at 26,000 ϫ g for 30 min at 4°C. Precipitated proteins were resuspended in Laemmli sample buffer containing 10% saturated Tris base and normalized according to the OD 600 value of the different cultures. Proteins were analyzed by 15% SDS-PAGE and immunoblotting.
Immunoblotting. For detection of proteins, samples were subjected to 12.5 or 15% SDS-PAGE, transferred onto a nitrocellulose membrane (Bio-Rad), and probed with polyclonal antibodies against EspA, EspB, EspF, Tir, EscN, and EscO, which were generated by subcutaneous immunization of rabbits with purified recombinant proteins. Immunoblotting with horseradish peroxidase (HRP)-conjugated anti-His (Pierce), antiDnaK (MBL International), or antihemagglutinin (anti-HA; Thermo Scientific) monoclonal antibodies was performed following the manufacturer's recommendations. Secondary antibodies were HRP-conjugated goat antirabbit or goat antimouse (Santa Cruz Biotechnology). Detection was performed using an ECL Western blotting kit (Amersham) or Immobilon Western chemiluminescent HRP substrate (Millipore), and bands were visualized on X-ray films (Kodak). Animals were handled and cared for according to the official Mexican guidelines (license A5281-01) with the local Animal Care Committee approval and in accordance with the NIH Guide for the Care and Use of Laboratory Animals (94) .
Production and purification of recombinant proteins. E. coli BL21(DE3)/pLysS (BDP) cells carrying plasmid pNEescO were grown in 300 ml of LB broth at 30°C to an OD 600 of 1.0. Protein production was induced with 0.5 mM IPTG (isopropyl-␤-D-thiogalactopyranoside), and incubation was continued for 4 h at 20°C. BDP cells containing plasmid pAEescN or pAEescN K183E were grown in 500 ml of LB broth at 30°C to an OD 600 of 0.6. IPTG was added to a final concentration of 0.1 mM, and incubation was continued for 4 h. E. coli M15 cells transformed with plasmid pAQescL or pAQescL ⌬89 were grown in 400 ml of LB broth at 30°C to an OD 600 of 0.8. IPTG was added to a final concentration of 0.1 mM, and incubation was continued for 4 h at 20°C. Salmonella enterica serovar Typhimurium SJW1368 cells containing plasmid pMTescO or pATescN were grown in 400 ml of LB broth at 37°C to an OD 600 of 0.8. IPTG was added to a final concentration of 0.5 mM and 0.1 mM, respectively, and incubation was continued for 4 h at 20°C and 30°C, respectively. The induced bacterial cultures were collected by centrifugation (8,000 ϫ g, 10 min) and stored at Ϫ20°C.
His-EscN recombinant protein was purified as previously reported (33) . For purification of His-EscO, His-EscL, and His-EscL ⌬89 , the cells were thawed, resuspended in binding buffer (20 mM Tris-HCl, pH 8.0, 0.5 M NaCl) with 1 mM phenylmethylsulfonyl fluoride and 100 g/ml lysozyme, and sonicated. Cell lysates were harvested (27,000 ϫ g, 30 min), and the soluble fractions were clarified after further centrifugation (145,000 ϫ g, 1 h) and loaded onto Ni-nitrilotriacetic acid (NTA) agarose columns (Qiagen) preequilibrated with binding buffer. After extensive washing with binding buffer containing 60 mM and 70 mM imidazole, proteins were eluted with 500 mM imidazole. His-FliJ and His-FliI were purified from Salmonella SJW1368 cells carrying plasmid pMM406 or pMM1702, following the procedures described above for His-EscO and His-EscN, respectively. Purified recombinant proteins were dialyzed overnight against TN buffer (20 mM Tris-HCl, pH 7.5, 0.5 M NaCl). The protein concentration was determined by using a Bio-Rad protein assay dye-binding reagent.
Pulldown assays. The soluble fractions of cultures of E. coli BDP cells carrying plasmid pNEescO, E. coli M15 cells carrying plasmid pAQescL ⌬89 , and Salmonella SJW1368 cells carrying plasmids pATescN and pMTescO were obtained by inducing and lysing as described above. The respective supernatants were mixed and incubated with gentle shaking for 1 h at 4°C. Then, 200 l of preequilibrated Ni-NTA resin was added to the mixture and the mixture was incubated for a further 1 h at 4°C. After collecting the mixture through a column, it was washed three times with 10 ml of TN buffer containing 30, 60, and 75 mM imidazole, respectively. Proteins were eluted in TN buffer containing 500 mM imidazole as 200-l fractions. The eluted proteins were resolved by SDS-PAGE and analyzed by immunoblotting.
Yeast two-hybrid (Y2H) assays. The Matchmaker GAL4 two-hybrid system 3 (Clontech) was used to examine protein-protein interactions in vivo as previously described (58) . Two-hybrid analyses were carried out following the manufacturer's instructions. Briefly, plasmid constructs were created by cloning the respective genes into the pGBKT7 (GAL4 DNA binding domain [BD] ) and pGADT7 (GAL4 activation domain [AD]) plasmid vectors ( Table 1 ). The constructs were cotransformed into Saccharomyces cerevisiae AH109 cells using the lithium acetate transformation procedure. Yeast cotransformants were selected for the presence of both plasmids on synthetic-dropout (SD) medium plates lacking leucine and tryptophan. Protein interactions were selected by the use of 10-fold serial dilutions spotted onto medium-stringency SD medium plates lacking leucine, tryptophan, and histidine. Plates were incubated at 30°C for 3 to 9 days. The manufacturer (Clontech) provided positive and negative controls (Table 1) . ATPase activity. ATP hydrolysis was determined by following a modification of the malachite green colorimetric assay, as previously described (33) . The reaction mixtures contained 0.25 M His-EscN, 3 mM ATP, 4 mM MgCl 2 , and 100 mM Tris-HCl, pH 8.0. The reaction mixture was incubated at 37°C with increasing molar ratios of His-EscO (0.25 to 2.25 M), and 100 l of the mixture was taken at different time points for inorganic phosphate determination. ATPase specific activity was calculated from the slopes of the curves from time course analyses.
When
Motility assays. Freshly transformed colonies of Salmonella SJW1103 cells carrying the pMTescO or pMM404 plasmid and Salmonella enterica MKM40 cells carrying the pMATescO or pACTrcJ plasmid (Table 1) were inoculated into soft tryptone agar plates (60) with or without 1 mM IPTG and incubated at 37°C for 5 h.
Bioinformatics analysis. The EscO, YscO, CdsO, Cpn0706, SsaO, HrpO, and FliJ amino acid sequences were analyzed using different software. The molecular masses were calculated using the ProtParam tool (http://web.expasy.org/protparam/) (61) . Isoelectric points were calculated using the Pepstats program (http://emboss.bioinformatics.nl/cgi -bin/emboss/pepstats). Identity and similarity percentages were obtained using EMBOSS Stretcher software (http://www.ebi.ac.uk/Tools/psa /emboss_stretcher). The program parameters were modified to a gap penalty of 20 for those protein alignments opening several gaps. The percent ␣-helical content was predicted with the CFSSP server (http://www .biogem.org/tool/chou-fasman). Coiled-coil conformation probability was predicted using the MultiCoil algorithm (http://groups.csail.mit.edu /cb/multicoil/cgi-bin/multicoil.cgi) (62) .
EscO structural modeling. The EscO three-dimensional model was built using the I-TASSER server (http://zhanglab.ccmb.med.umich.edu /I-TASSER/) (63, 64) . The TM-align server was used to perform all pairwise structural alignments between the EscO predicted model and CdsO (CT670), FliJ, and the ␥ subunit from the F 1 ATPase. The structural model for the EscN homohexameric ring was created by superimposing the atomic coordinates of the EscN monomer (PDB accession number 2OBL) onto the X-ray structure of the bovine F 1 ATPase ␣ 3 ␤ 3 heterohexamer (PDB accession number 1E79, chains A to F) using the MatchMaker module of the UCSF Chimera (version 1.8) program (65) . Once aligned with the ␥ subunit of the F 1 ATPase (PDB accession number 1E79, chain G), EscO was fitted in place of the ␥ subunit.
RESULTS
EscO shares similarities with members of the YscO and FliJ protein families. The EPEC escO gene is encoded within the LEE3 operon between escN, which encodes the T3SS ATPase (33, 34) , and escP, which encodes a protein that participates in needle length control and the regulation of protein secretion (58) (Fig. 1) . Although an analysis of the LEE using the PSI-BLAST program did not identify any EscO homolog outside the LEE pathogenicity island (54) , escO shares synteny with genes in other virulence T3S gene clusters and with fliJ, which encodes a soluble component of the flagellar type III export apparatus (46, 48) ; i.e., all are flanked by the genes encoding the ATPase and the protein regulating needle or hook length (Fig. 1A) . The proteins encoded by these genes show moderate similarity and share several characteristics, like a low molecular mass (14 to 20 kDa), a considerable proportion of charged residues, a neutral to basic pI, and an ␣-helical propensity that tends to adopt a coiled-coil conformation (Fig. 1A and B) . Furthermore, multiple-amino-acid-sequence alignment showed various highly conserved residues among members of the YscO protein family (PF 07321) and EscO, as well as a nearly identical predicted secondary structure (see Fig. S1 in the supplemental material). Some amino acid sequence similarity and a predominantly ␣-helical structure are also shared between EscO and the flagellar FliJ proteins (see Fig. S2 in the supplemental material) .
EscO is essential for secretion of all classes of type III substrates. To assess the requirement of EscO for type III protein secretion in EPEC, we replaced the chromosomal escO gene with a kanamycin resistance cassette, creating mutant strain ⌬escO (Table 1). It has previously been shown that EPEC EscO is needed for translocator protein secretion (53) . In this study, we confirm and extend this finding. Proteins secreted to the supernatant by the wild-type, ⌬escN, and ⌬escO strains were recovered and analyzed by SDS-PAGE and immunoblotting. As shown in Fig. 2A , wildtype EPEC secreted translocator (EspA, EspB, and EspD) and effector (Tir and EspF) proteins, whereas the escO mutant strain lost its competence for secretion of these type III substrates ( Fig. 2A , top and S panels). The ⌬escN strain was used as a negative control. EspC is an autotransported protein. To confirm that EscO is indispensable for protein secretion, we showed that the failure of the ⌬escO mutant to secrete proteins is not due to a defect in protein production ( Fig. 2A, panels P) . The chaperone DnaK was used as a loading control. Additionally, we evaluated the secretion of an early substrate, the inner rod protein EscI C-terminally fused to a double HA tag (EscI-HA), and of the Nle effectors (NleD-HA, NleH-HA, and NleI-HA). As shown in Fig. 2B , these substrates were not detected in the supernatant of either the ⌬escO or the ⌬escN mutant strains (Fig. 2B , panels S), even though protein production was not affected in the ⌬escO background (Fig. 2B , panels P). Moreover, complementation of the null strain showed that the wild-type secretion profile was entirely restored when EscO or His-EscO was produced in the ⌬escO mutant background, indicating that the escO deletion mutant is nonpolar and that the recombinant N-terminally His-tagged version of EscO is functional ( Fig. 2A, top) . These results indicate that EscO is crucial for secretion of all known categories of type III substrates and suggest that it is a component of the export apparatus.
EscO interacts with the ATPase EscN and stimulates its hydrolytic activity. Previous studies in the flagellar T3SS reported that FliJ interacts with the ATPase FliI, promoting its oligomerization and increasing its hydrolytic activity (28, 40 ). An interaction with the T3SS ATPase has also been demonstrated for the FliJ virulence counterparts Cpn0706 and Spa13 (44, 66) . However, it was not detected for CdsO (42) , suggesting that this interaction is not conserved among all T3SSs. It has also been reported that YscO is not required for the assembly of the ATPase YscN (39) . Therefore, the role of this group of proteins in the ATPase functioning of the virulence T3SSs remains unknown. Whether any of the FliJ virulence counterpart proteins affects ATPase activity has likewise not yet been determined.
In order to explore a possible functional relationship between EscO and EscN, we first sought to evaluate a physical interaction between these proteins. We performed copurification assays by mixing the soluble lysates of cells producing N-terminally histidine-tagged EscO and untagged EscN. The lysate mixture was sub-jected to Ni-NTA affinity chromatography, and the results showed that untagged EscN coeluted with His-EscO in the pulldown assay (Fig. 3A) , indicating that EscN interacts with EscO. The identity of the proteins was confirmed by immunoblotting using anti-EscN and anti-EscO polyclonal antibodies. As a control, binding of EscN to the Ni-NTA resin was assayed in an identical manner, and no protein was detected in the elution fraction (Fig. 3A, right) . To verify this protein-protein interaction in vivo, we carried out a yeast two-hybrid (Y2H) assay. EscO was fused to the GAL4 DNA binding domain (BD), while EscN was fused to the GAL4 activation domain (AD). Growth of S. cerevisiae containing both fusions on SD medium lacking histidine indicated activation of transcription of the HIS3 reporter gene and confirmed the EscO-EscN interaction (Fig. 3B, right) . EscO fused to the GAL4 DNA BD together with the AD was used as an autoactivation control, and growth was not detected (Fig. 3B , right, EscOpGADT7).
Next, to investigate if EscO has an effect on the ATPase activity of EscN, we purified the N-terminally histidine-tagged proteins His-EscO and His-EscN. We have previously shown that both recombinant proteins are functional (Fig. 2) (33) . The rate of ATP hydrolysis by His-EscN (0.32 Ϯ 0.04 mol min Ϫ1 mg Ϫ1 ) (Fig. 3C,  arrowhead) was measured in the presence of increasing concentrations of His-EscO. The results showed that EscO stimulates EscN ATPase activity in vitro up to 10-fold (2.88 Ϯ 0.14 mol min Ϫ1 mg Ϫ1 ) at a 1:6 EscN/EscO molar ratio (Fig. 3C, arrow) . As a control, we generated EscN with a catalytic point mutation (HisEscN K183E ), which is unable to bind ATP (34) , and demonstrated that EscO did not activate this mutant version (Fig. 3C) , discarding the possibility that contaminants were present during protein purification. To our knowledge, this is the first report that any member of the virulence T3SSs is an activator of ATPase hydrolytic activity.
EscL interacts with EscO, inhibits EscN ATPase activity, and prevents the stimulation of ATP hydrolysis by EscO. In the flagellar T3SS, the ATPase complex is formed by the proteins FliH, FliI, and FliJ (24, 30) . In the EPEC T3SS, it has been shown that the ATPase EscN interacts with EscL, a putative negative regulator of ATPase activity (36) . In this study, we showed that EscO interacts with EscN (Fig. 3A) and sought to investigate whether it also as- sociates with EscL. Hence, we performed a pulldown assay by mixing the soluble lysates of cells producing N-terminally histidine-tagged EscL and untagged EscO. Due to solubility problems, we were unable to purify a sufficient amount of His-EscL for the pulldown assay, so we used an N-terminal truncated version of EscL lacking the first 89 residues (His-EscL ⌬89 ), based on what was previously reported for FliH in Helicobacter pylori (67) . The lysate mixture was subjected to Ni-NTA affinity chromatography, and the results showed that untagged EscO coeluted with His-EscL ⌬89 (Fig. 4A) , indicating that EscO interacts with EscL and that the first 89 residues of EscL are not required for this interaction. As a control, binding of EscO to the Ni-NTA resin was assayed in an identical manner, and unspecific binding was not detected (Fig.  4A, right) . The EscO-EscL interaction was confirmed in vivo with a Y2H assay, as described above (Fig. 4B) .
Next, we evaluated the effect of EscL on EscN ATPase activity. To this end, we first analyzed whether the truncated version of EscL could interact with EscN by pulldown assay. We observed that EscN coeluted with His-EscL ⌬89 (see Fig. S3 in the supplemental material), indicating that the first 89 residues of EscL are not required for the interaction with EscN. This interaction was corroborated in vivo by the Y2H assay (see Fig. S3 in the supplemental material). Then, we demonstrated that EscL inhibits EscN ATPase activity in vitro (Fig. 4C) . In this experiment, a small amount of EscL recombinant protein was needed, so we were able to use full-length His-EscL, which completely inhibited ATPase activity at a 1:2 EscN/EscL molar ratio (Fig. 4C) . We also examined the inhibition of ATPase activity by the EscL ⌬89 truncated protein and showed that this version also suppresses ATPase activity, although not as efficiently as the full-length protein does (84% inhibition) (Fig. 4C) . Furthermore, to test whether EscO was capable of stimulating EscN ATPase activity while being inhibited by EscL, EscO was added to the reaction mixture after the EscN-EscL complex was formed and the ATPase activity was inhibited. As shown in Fig. 4C , the inhibited ATPase could not be further stimulated by EscO (EscN/EscL/EscO molar ratio, 1:2:6), although the EscN hydrolytic activity returned to its basal level. The same effect was observed when inhibiting EscN with EscL ⌬89 (Fig. 4C) .
EscO can partially complement the swimming defect of a flagellar fliJ mutant strain and stimulates FliI ATPase activity. Because of the similarities between EscO and FliJ found in this study, we investigated the potential heterologous complementation of a flagellar fliJ mutant strain by the virulence counterpart protein EscO. For this, a Salmonella enterica fliJ-null strain, MKM40, was transformed with pACTrc-based plasmids pACTrcJ and pMATescO (Table 1) , which produce FliJ and EscO, respectively. The complementation test of transformed MKM40 cells was carried out on semisolid tryptone agar plates for motility assays. As shown in Fig. 5A , EscO was able to restore the motility of the fliJ-null strain, albeit not as efficiently as the homologous complementation with FliJ. In addition, we also tested for heterologous negative multicopy effects on the motility of Salmonella wild-type SJW1103 cells. It has previously been shown that the overproduction of FliJ has inhibitory effects on protein export and, therefore, motility (47) . Here we showed that EscO strongly inhibited the motility of Salmonella wild-type cells in the presence of the inducer IPTG (Fig. 5B) . These results suggest that EscO is capable of interacting with the flagellar ATPase FliI, promoting its partial functioning, and that it may also interact with other components In vivo EscO-EscN interaction. A Y2H assay was performed using S. cerevisiae strain AH109 cotransformed with pNGBKescO (GAL4BD-EscO) and pGADT7 or pNGADescN (GAL4AD-EscN). Cultures of cotransformants were 10-fold serially diluted and spotted onto SD medium lacking tryptophan and leucine (SD Ϫ Trp Ϫ Leu) and onto SD medium lacking tryptophan, leucine, and histidine (SD Ϫ Trp Ϫ Leu Ϫ His) to select for interacting proteins. Positive (pGADT7-T and pGBKT7-53) and negative (pGADT7-T and pGBKT7-Lam) controls were provided by Clontech. (C) Effect of EscO on the ATPase activity of EscN. Specific ATPase activity was determined by detection of inorganic phosphate release in a malachite green assay. His-EscN and His-EscN K183E (0.25 M each) were incubated with increasing amounts of His-EscO (0.25 to 2.25 M). Arrowhead, basal EscN ATPase activity; arrow, ATPase activity at a 1:6 EscN/EscO molar ratio. Standard deviations of three independent experiments are shown.
of the flagellar export apparatus. In order to get insight into this, we purified His-FliI and measured its ATPase activity in the presence of FliJ and EscO. The ATPase activity of FliI in the presence of EscO increased almost to the same extent as it did in the presence of FliJ (Fig. 5C) . These results strongly suggest that EscO is a functional counterpart of FliJ.
The predicted tertiary structure of EscO is highly similar to the crystal structure of FliJ. In this study, we have shown that EscO shares functional characteristics with members of the YscO and FliJ protein families. In order to determine if EscO also shares structural features with this group of proteins, the tertiary structure of EscO was modeled using the I-TASSER In vivo EscO-EscL interaction. A Y2H assay was performed using S. cerevisiae strain AH109 cotransformed with pNGBKescO (GAL4BD-EscO) and pGADT7 or pNGADescL ⌬89 (GAL4AD-EscL ⌬89 ). Cultures of cotransformants were 10-fold serially diluted and spotted onto SD medium lacking tryptophan and leucine (SD Ϫ Trp Ϫ Leu) and onto SD medium lacking tryptophan, leucine, and histidine (SD Ϫ Trp Ϫ Leu Ϫ His) to select for interacting proteins. Positive (pGADT7-T and pGBKT7-53) and negative (pGADT7-T and pGBKT7-Lam) controls were provided by Clontech. (C) EscN ATPase activity in the presence of EscL and of EscL and EscO. Specific ATPase activity was determined by detection of inorganic phosphate release in a malachite green assay. His-EscN (0.25 M) was incubated with 0.5 M His-EscL or His-EscL ⌬89 , and the ATPase activity was determined from ATP hydrolysis time course analysis. The effect of EscO on the EscL-inhibited ATPase was determined by preincubating EscN with His-EscL or His-EscL ⌬89 for 5 min and starting the reaction with 1.5 M His-EscO and 3 mM ATP. Standard deviations of three independent experiments are shown. server (63, 64) . Remarkably, among the 10 best templates in the Protein Data Bank (PDB) database used to generate the EscO models, we found the crystal structures of Chlamydia CdsO (CT670, PDB accession number 3K29) and Salmonella enterica FliJ (PDB accession number 3AJW), previously identified to be putative YscO homologs (28, 39, (41) (42) (43) . Indeed, the crystal structure of the T3SS protein YscO from Vibrio parahaemolyticus (PDB accession number 4MH6) was used as the template by the server to generate the EscO model in a more recent I-TASSER search. The predicted tertiary structure of the EscO protein consists of two long antiparallel helices forming a coiled coil (Fig. 6A ) which closely resembles that in the three-dimensional (3D) structures of CdsO and FliJ (Fig. 6B and C) and the coiled-coil domain of the F 1 ATPase ␥ subunit (Fig. 6D) . Structural alignments between the EscO model and the structures of CdsO and FliJ revealed striking similarities with root mean square deviations of 2.75 and 3.34 Å, respectively ( Fig. 6E and data not shown) . In addition, since our functional and predicted structural data suggest that EPEC EscO has a role equivalent to that of the flagellar FliJ protein, i.e., interacting within the center of the ATPase homohexameric ring in a manner similar to the ␥ subunit in the F 1 ␣ 3 ␤ 3 heterohexamer, we built an in silico model of an EscN 6 -EscO complex (Fig. 6F and G).
DISCUSSION
In this work, we studied the role of EscO (previously Orf15 or EscA) in injectisome biogenesis in EPEC. Although EscO has no significant sequence similarity to any protein outside the LEE of the A/E enteropathogens, our in silico analyses suggest that it might be the virulence counterpart of the flagellar FliJ protein. Here, we provide experimental evidence that confirms this prediction and propose that EscO is a distant homolog of FliJ.
The proteins encoded by genes syntenic to escO have modest levels of amino acid identity to EscO (10 to 18%); nonetheless, they share several molecular characteristics (Fig. 1) . Likewise, EscO showed considerable similarity to members of the YscO protein family (see Fig. S1 in the supplemental material) and a predicted tertiary structure similar to that of YscO (68); accordingly, it was designated EscO following the Yersinia nomenclature. In addition, it has been shown for some members of this group of proteins, e.g., YscO, InvI, Spa13, and FliJ, that they are required for protein secretion in their respective T3SSs (43, 45, 69, 70) . In this study, we demonstrated that EscO is essential for the secretion of all classes of T3SS substrates (Fig. 2) suggesting that it is a component of the export apparatus. A global effect on secretion (including early, middle, and late substrates) has also been re- ported for InvI, YscO, and the export machinery component FliJ (39, 43, 45, 46) .
In order to gain insight into the role of EscO in the secretion process, we investigated its potential protein-protein interactions with soluble components of the export apparatus. Both the virulence and the flagellar export apparatuses contain a membraneembedded export gate composed of six proteins in the flagellum (FlhA, FlhB, FliP, FliQ, FliR, and FliO) and five homolog proteins in the EPEC injectisome (EscV, EscU, EscR, EscS, and EscT; FliO has no identified virulence counterpart) plus an ATPase complex comprising three soluble proteins in the flagellum (FliI, FliH, and FliJ) and its two homolog components in the injectisome (EscN and EscL) (1, 6) . Prior to this study, no equivalent of the FliJ protein had been identified in the EPEC T3SS. Here, we obtained successful copurification of untagged EscN with His-EscO and untagged EscO with His-EscL by pulldown assays and corroborated these novel interactions in vivo by use of a Y2H system (Fig.  3 and 4) , which suggests that EscO together with EscL and EscN constitutes the EPEC injectisome ATPase complex. While the manuscript was in preparation, Lin et al. identified these protein interactions in EHEC, although they participated in a different context (71) . In this study, we extended these findings by evaluating the effects of these interactions on ATPase activity and proposing a model on their contribution to the secretion process.
FliJ is structurally and functionally similar to the ␥ subunit of the F o F 1 ATPase (28, 29) , and it promotes FliI oligomerization (28) and an increase in ATPase activity (28, 40) . While some members of the virulence YscO/InvI/Spa13 protein family are known to interact with the ATPase, whether they promote oligomerization or ATP hydrolysis remains elusive. Recent data suggested that YscO in Yersinia is dispensable for the assembly of the ATPase YscN (39) . Therefore, to analyze the role of EscO in the ATPase complex, we evaluated its effect on EscN enzymatic activity. Our results showed that EscO stimulates EscN ATPase activity up to 9 times at a 6:1 molar ratio (Fig. 3C) . In this regard, it is known that oligomerization of T3SS ATPases is required for maximum activity (72) (73) (74) . The enzymatic activity of EscN showed positive cooperativity, indicating that oligomerization is coupled to an increase in ATP hydrolysis (33) . Moreover, we identified different oligomeric forms of EscN, but with a predominating monomer, which suggested a dynamic monomer-multimer equilibrium, so we proposed that EscN required other secretion apparatus components for efficient oligomerization (33) . It is then possible that EscO could promote and stabilize EscN oligomer formation.
Here, we demonstrated that EscL inhibits EscN enzymatic activity and that EscO cannot completely stimulate ATPase activity under this condition (Fig. 4C) , even when using an EscO excess at a 1:2:10 EscN/EscL/EscO molar ratio (data not shown). In the flagellar system, it has been shown that FliH interacts within the first residues of FliI and FliJ interacts in the C-terminal region of FliI (28, 75) ; consistent with this, we have experimental evidence showing that EscL interacts with the N-terminal region of EscN, while EscO interacts with its C-terminal domain (unpublished data). Thus, a heterotrimeric EscN-EscL-EscO complex could be formed in the same manner as the FliI-FliH-FliJ complex (30) , which is in agreement with the fact that EscO could not displace EscL from EscN but was able to restore ATPase activity to its basal level (Fig. 4C) . Further studies will be required to determine the binding affinities for interactions among these components.
The above-mentioned results strongly indicate that EscO is the T3SS virulence equivalent of the flagellar FliJ protein. To corroborate the suggestion that EscO is a functional analog of FliJ, we performed a heterologous complementation assay and demonstrated that EscO can partially complement the motility deficiency of a Salmonella fliJ mutant strain (Fig. 5A ). In accordance with this result, we also showed that EscO stimulates FliI ATPase activity (Fig. 5C ). To our knowledge, this is the first example of an EPEC virulence T3SS protein complementing a flagellar T3SS mutant, an interesting result, considering the low level of amino acid identity between these proteins ( Fig. 1A; see Fig. S2 in the supplemental material). The same experiment was performed with the more conserved ATPases EscN and FliI, but EscN was unable to restore the swimming defect of a Salmonella fliI mutant strain (data not shown), despite their significant protein similarity. Additionally, it is probable that EscO also interacts with other components of the flagellar export apparatus, since its overproduction in Salmonella wild-type cells severely inhibits motility (Fig. 5B) . The strong negative multicopy effect that FliJ exerts on Salmonella motility is also observed in the absence of FliH and FliI; hence, it has been attributed to its interaction with FlhA (50), suggesting that EscO can interact with FlhA. By the same token, it has been shown that Spa13 interacts with MxiA (FlhA homolog) (44) . Therefore, we hypothesize that in the same manner, EscO interacts with EscV.
Overall, these results suggest that the EscO tertiary structure should be similar to the solved structure of FliJ. The I-TASSER model of EscO confirmed this prediction (Fig. 6) . Like the CdsO (CT670) and FliJ (28, 42) structures, the predicted structure of EscO consists of a single coiled coil with two long helices, which is also similar to the coiled-coil part of the F 1 ␥ subunit. Therefore, it seems unlikely that the EscO protein has four helices, as previously predicted (53) . Considering the structural similarities of EscO with FliJ and the F 1 ␥ subunit and of EscN with FliI and the F 1 ␣ and ␤ subunits, we generated a model of the EscN-EscO complex ( Fig. 6F and G) .
It has been reported that EscO (previously EscA) localizes to the periplasm, where it interacts with the secretin EscC and may function as a structural component of the T3SS (53) . The periplasmic role of this protein has not been previously described for any member of the YscO/FliJ protein family. Nonetheless, these are multifunctional proteins; e.g., FliJ and its virulence counterparts have been reported to act as chaperone escort proteins (40, 43, 69) . In this regard, we have also determined that EscO interacts with the translocator chaperones CesD and CesD2 (unpublished results), which seems to be an additional conserved function of these proteins. Moreover, the EscO homolog in EHEC was recently found to interact with the CesA2 chaperone, the EspA filament protein, and the regulator Mpc (71) . Here, we describe a new cytosolic function for EscO as an ATPase activator. Therefore, EscO could be considered a moonlighting protein within the T3SS.
A model that offers a current view of the T3SS export apparatus in EPEC based on the interactions found in this work, together with the ones observed in the flagellar and other virulence T3SSs, is presented in Fig. 7 . In the cytoplasm, an EscN-EscL complex is formed in which EscL suppresses the ATP hydrolytic activity of EscN (Fig. 4C) , until it can be coupled to protein secretion (37, 38, 76, 77) . It is unlikely that EscO interacts with this complex in the cytoplasm, since the ATPase activity would be derepressed to its basal level (Fig. 4C) . The EscN-EscL complex and EscO are sepa-rately recruited to the EscQ C-ring component prior to its docking to the export gate (36, 69, (78) (79) (80) (81) . The C ring increases the local concentration of these components close to the export apparatus, and the interaction between EscL and EscO ( Fig. 4A and B) (41, 48, 49) releases the EscN-EscL-EscO complex (78) . The interaction of EscL with components of the membrane-embedded export apparatus, e.g., EscV (44, 82, 83) , induces a conformational change in EscL, which allows EscO to promote EscN oligomerization and stimulation of ATPase activity (Fig. 3C) (28) . EscL would function as a lateral stalk (F o F 1 ATPase b and ␦ subunits), allowing the stable association of homohexameric EscN (the ␣ 3 ␤ 3 heterohexamer) and its central stalk EscO (the ␥ subunit) with the export platform (6, (26) (27) (28) 34) . The chaperone-effector complexes can also be recruited to the sorting platform (EscQ) before engaging at the ATPase for chaperone dissociation and substrate unfolding (84) (85) (86) (87) . In this scenario, the EscO-EscV interaction might couple ATP hydrolysis by EscN with efficient proton motive force-driven protein secretion (30, 50, 51) .
